MedTrace Logo

Pneumonia Policy Formation in Pakistan

NCT03784274 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-06-10

No results posted yet for this study

Summary

In Pakistan, numerous policies have been formulated in the past on pneumonia management translated into various programs. However, despite completion, the state of pneumonia mortality remains unchanged as no sustainable solutions have been yielded by these programs. This is probably because there was no ownership of these policies and programs at the provincial, district and community level. We, therefore, plan to understand pneumonia related policy environment within Pakistan to identify gaps in this system through a two phased study. The first will be qualitative with key informant interviews conducted from relevant stakeholders, e.g, policy makers, practitioners, academicians, researchers etc., to understand how policies are conceptualized. Data will be analyzed through an integrated approach in a software. The second phase will social network research conducted by studying actors linked together by social relations. This will be achieved through net mapping exercise to understand, discuss, and visualize how various actors influence pneumonia related outcomes through technical and financial links. Data will be analyzed through the Organizational Risk Analyzer (ORA) which is a meta-network assessment and analysis tool. This study will be the first of its kind for under-five pneumonia and will guide policy makers for creating effective solutions to combat the disease.

Conditions

Interventions

BEHAVIORAL

Stakeholder analysis

• INCLUSION CRITERIA FOR NET MAPPING ACTIVITIES: Those respondents who are directly involved or knowledgeable about pneumonia related policy environment in the country/province. * Respondents who consent to participate in the study. * Respondents belonging to Sindh, Punjab, Baluchistan, KPK and Islamabad. EXCLUSION CRITERIA: • Respondents belonging to Gilgit-Baltistan (GB), Azad Jammu and Kashmir (AJK) and Federally Administered Tribal Area (FATA). Reasons of their exclusion are newly developed governance system (GB), separate governance (AJK) and security threat (FATA).

Sponsors & Collaborators

  • Maternal, Neonatal and Child Health Research Network

    collaborator OTHER

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Dr Tabish Hazir, MBBS, FRCPCH · Maternal, Neonatal and Child Health Research Network

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2020-01-01
Completion
2020-04-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03784274 on ClinicalTrials.gov